An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder. [PDF]
Bai WZ, Zhou SY, Mou YY, Peng L, Li LL.
europepmc +1 more source
Targeting MET and KRAS G12C co-occurring mutation in metastatic adenoid cystic carcinoma of the trachea: a case report. [PDF]
Zhang L, Wang T, Xu Y, Ji Y, Nie K.
europepmc +1 more source
Trametinib-induced Hyponatremia in a Patient With Craniopharyngioma and Diabetes Insipidus. [PDF]
Gunasekara B +4 more
europepmc +1 more source
Microwave-assisted synthesis and functionalization of 2-arylimidazo[1,2-a]pyrimidin-5(8H)-ones. [PDF]
Camargo D +3 more
europepmc +1 more source
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial. [PDF]
Slørdahl KS +18 more
europepmc +1 more source
BRAF <sup><b>V600E</b></sup> Metastatic Synovial Sarcoma Treated with BRAF & MEK Inhibitors Achieves Complete Response. A Case Report & Literature Review. [PDF]
Burg D +20 more
europepmc +1 more source
Ensifentrine Added on to Dual Bronchodilator or Triple Therapy Demonstrates Clinically Meaningful Improvement in CAT Score in Symptomatic Patients with Chronic Obstructive Pulmonary Disease. [PDF]
Siler TM +5 more
europepmc +1 more source
Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma. [PDF]
Milewski D +21 more
europepmc +1 more source

